Aspire BioPharma, Inc. Cash Flow Reinvestment Rate
Latest as of December 2024:
0.00x
Aspire BioPharma, Inc. cash flow reinvestment rate. Aspire BioPharma, Inc. (ASBP) has a Cash Flow Reinvestment Rate of 0.00x as of December 2024, reinvesting $4.00 (capex $4.00 ) from operating cash flow of $479.57K. Explore ASBP operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
$4.00
Capex + Investments
Operating Cash Flow
$479.57K
USD
Capital Expenditures
$4.00
USD
Aspire BioPharma, Inc. Cash Flow Reinvestment Rate by Year (None–None)
Aspire BioPharma, Inc. cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Aspire BioPharma, Inc.. For the full cash flow conversion analysis, see how efficiently does Aspire BioPharma, Inc. generate cash.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow